{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Management of Left Ventricular Pseudoaneurysm"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised controlled trial aimed to evaluate the effectiveness of advanced multimodality imaging"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a tertiary care hospital, the study included patients with suspected or diagnosed LVP"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to either the intervention group, which received cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) in addition to echocardiography, or the control group, which received standard echocardiography alone"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to evaluate the effectiveness of advanced multimodality imaging in diagnosing and managing LVP"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the accuracy of LVP diagnosis, assessed over a 6-month period"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group, with recruitment spanning from January 2020 to June 2021"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group demonstrated a significant improvement in diagnostic accuracy compared to the control group (mean difference = 15%, 95% CI 10% to 20%; p < 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were minimal, occurring in 3% of the intervention group and 1% of the control group, primarily mild gastrointestinal side-effects"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: This study was supported by the National Institutes of Health"
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}